Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$1.70
-0.6%
$1.82
$1.26
$5.46
$63.94M0.0198,079 shs15,349 shs
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$27.62
-0.7%
$30.40
$25.86
$39.08
$247.26M1.3527,211 shs28,816 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$33.00
+10.4%
$29.59
$5.17
$39.50
$255.73M1.1954,770 shs142,242 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$8.61
-1.6%
$9.05
$8.15
$22.40
$243.66M2.1207,747 shs116,292 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-1.22%-5.03%-8.60%-25.44%-67.86%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-0.72%-4.56%-11.42%-18.62%-6.85%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
+10.40%+5.20%+11.56%+3,299,999,900.00%+3,299,999,900.00%
ZimVie Inc. stock logo
ZIMV
ZimVie
-1.60%-9.65%-1.60%-25.78%-44.70%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
1.8841 of 5 stars
3.23.00.00.00.61.70.6
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
2.2732 of 5 stars
3.51.00.00.02.81.70.6
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
3.3272 of 5 stars
3.35.00.00.03.31.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
2.33
Hold$8.50400.00% Upside
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$49.5079.22% Upside
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.00
N/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3389.70% Upside

Current Analyst Ratings Breakdown

Latest EDAP, SMTI, SNWV, and ZIMV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral
5/15/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$51.00 ➝ $53.00
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/4/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$8.00 ➝ $2.00
3/28/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$5.00 ➝ $4.50
3/28/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00 ➝ $19.00
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$46.00 ➝ $46.00
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $51.00
(Data available from 6/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$69.18M0.92N/AN/A$1.18 per share1.44
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$86.67M2.83N/AN/A$4.45 per share6.21
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$32.63M8.66N/AN/A($1.49) per share-22.15
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M0.53$1.83 per share4.71$13.83 per share0.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$20.58M-$0.62N/AN/AN/A-34.45%-51.42%-26.43%8/27/2025 (Estimated)
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$9.66M-$1.34N/AN/AN/A-12.48%-29.22%-13.20%8/11/2025 (Estimated)
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$31.37M-$4.56N/AN/A-89.86%N/A-145.76%N/A
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.71N/AN/A-4.40%5.53%2.84%8/7/2025 (Estimated)

Latest EDAP, SMTI, SNWV, and ZIMV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$0.16-$0.20-$0.04-$0.20$16.56 million$16.37 million
5/14/2025Q1 2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.31-$0.41-$0.10-$0.41$23.48 million$23.43 million
5/9/2025Q1 2025
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/A-$0.66N/A-$0.66N/A$9.34 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
3/27/2025Q4 2024
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$0.11-$0.05+$0.06-$0.05$20.83 million$22.69 million
3/25/2025Q4 2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.19-$0.18+$0.01-$0.18$22.75 million$26.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
N/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.10
1.74
1.21
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.18
2.77
2.54
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/A
0.40
0.28
ZimVie Inc. stock logo
ZIMV
ZimVie
0.58
2.14
1.48

Institutional Ownership

CompanyInstitutional Ownership
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
62.74%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
42.53%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.23%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
42.60%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
36.60%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
23037.39 million37.31 millionOptionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
608.89 million5.10 millionNot Optionable
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
408.56 million5.43 millionN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million27.01 millionOptionable

Recent News About These Companies

ZimVie: Screening Cheap (Rating Upgrade)
Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system
Needham Remains a Hold on ZimVie Inc (ZIMV)
ZimVie initiated with a Buy at B. Riley

New MarketBeat Followers Over Time

Media Sentiment Over Time

EDAP TMS stock logo

EDAP TMS NASDAQ:EDAP

$1.70 -0.01 (-0.58%)
As of 06/18/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

Sanara MedTech stock logo

Sanara MedTech NASDAQ:SMTI

$27.62 -0.20 (-0.72%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$29.15 +1.53 (+5.54%)
As of 06/18/2025 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Sanuwave Health stock logo

Sanuwave Health NASDAQ:SNWV

$33.00 +3.11 (+10.40%)
As of 06/18/2025 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$8.61 -0.14 (-1.60%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$8.60 -0.01 (-0.12%)
As of 06/18/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.